Bruce Rutherford
Director/Board Member at Dentigenix, Inc.
Profile
Bruce Rutherford is currently a Director at Dentigenix, Inc. He was previously a Vice President-Clinical Development at Novalar Pharmaceuticals, Inc. and a Chief Scientific Officer at Dentigenix, Inc. Rutherford holds a doctorate degree from the University of Rochester and an undergraduate degree from the University of Washington.
Bruce Rutherford active positions
| Companies | Position | Start |
|---|---|---|
Dentigenix, Inc.
 Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Director/Board Member | - |
Former positions of Bruce Rutherford
| Companies | Position | End |
|---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Bruce Rutherford
| University of Washington | Undergraduate Degree |
| Rochester Christian University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Bruce Rutherford
